Riggs Asset Managment Co. Inc. Amgen Inc Transaction History

Riggs Asset Managment Co. Inc.

$358 Million
Q3 2024

A detailed history of Riggs Asset Managment Co. Inc. transactions in Amgen Inc stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 356 shares of AMGN stock, worth $99,704. This represents 0.03% of its overall portfolio holdings.

Number of Shares

356

Previous 356 -0.0%

Holding current value

$99,704

Previous $111,000 2.7%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $1,576 - $1,915	6 Added 1.71%	356 $111,000
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $62,108 - $74,973	-231 Reduced 39.76%	350 $99,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $4,515 - $5,504	-20 Reduced 3.33%	581 $140,000
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $4,489 - $5,063	20 Added 3.44%	601 $135,000
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $24,224 - $26,957	-105 Reduced 15.31%	581 $141,000
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $14,033 - $15,524	-64 Reduced 8.53%	686 $166,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $16,904 - $19,346	-85 Reduced 10.18%	750 $169,000
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $5.3 Million - $6.21 Million	-24,955 Reduced 96.76%	835 $178,000
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $922,407 - $1.02 Million	3,949 Added 18.08%	25,790 $6.29 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $216,140 - $251,876	-974 Reduced 4.27%	21,841 $5.43 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $122,038 - $145,325	-564 Reduced 2.41%	22,815 $5.25 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $280,641 - $312,096	-1,196 Reduced 4.87%	23,379 $5.92 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $6,923 - $8,495	-35 Reduced 0.14%	24,575 $5.8 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $114,082 - $151,304	-626 Reduced 2.48%	24,610 $4.99 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $276,435 - $355,315	1,461 Added 6.15%	25,236 $6.08 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $28,728 - $34,422	165 Added 0.7%	23,775 $4.6 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $151,363 - $177,432	-908 Reduced 3.7%	23,610 $4.35 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $28,215 - $31,805	-156 Reduced 0.63%	24,518 $4.66 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $6,309 - $7,087	38 Added 0.15%	24,674 $4.56 Million
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $107,757 - $125,928	636 Added 2.65%	24,636 $4.2 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $5,401 - $6,034	32 Added 0.13%	24,000 $4.17 Million
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $4.01 Million - $4.58 Million	23,968	23,968 $4.47 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.

Account

Riggs Asset Managment Co. Inc. Amgen Inc Transaction History